WAe001-A-2F

General

Cell Line

hPSCreg name WAe001-A-2F
Cite as:
WAe001-A-2F (RRID:CVCL_D6SS)
Cell line type Human embryonic stem cell (hESC)
Similar lines
WAe001-A
(WA01, H1)
WAe001-A-A
(H1X-10/H1.2-20)
WAe001-A-2B
(H1-NSD2-/-)
WAe001-A-B
(H1X-59/H1.2-6)
WAe001-A-C
(H1X-10/H1.3-62)
WAe001-A-D
(H1X-59/H1.3-68)
WAe001-A-E
(H1X-10/H1.4-4)
WAe001-A-F
(H1X-59/H1.4-5)
WAe001-A-86
(H1.139, H1.1-39)
WAe001-A-72
(H1-FTO-Knockout-13)
WAe001-A-31
(H1_RB1ex1_D6)
WAe001-A-32
(H1_RB1ex1_E9)
WAe001-A-87
(H1.213, H1.2-13)
WAe001-A-G
(H1X-10/H1.5-1)
WAe001-A-88
(H1.2-124, H1.2124)
WAe001-A-1N
(H1-FIS1-KO, WA01-FIS1-KO)
WAe001-A-89
(H1.3-64, H1.364)
WAe001-A-H
(H1X-59/H1.5-33)
WAe001-A-1O
(WA01-MYB-KO, H1-MYB-KO)
WAe001-A-77
(H1 RYBP-FLAG-HA KI)
WAe001-A-90
(H1.3-191, H1.3191)
WAe001-A-I
(H1.0-29/H1.1-13)
WAe001-A-41
(H1-RNF2-KO-1#)
WAe001-A-J
(H1.0-102/H1.1-34)
WAe001-A-42
(H1-RNF2-KO-2#)
WAe001-A-K
(H1.0-29/H1.2-31)
WAe001-A-1
(H1.1, WA01.1)
WAe001-A-L
(H1.0-102/H1.2-6)
WAe001-A-M
(H1.0-29/H1.3-22)
WAe001-A-N
(H1.0-102/H1.3-90)
WAe001-A-91
(H1.4-126, H1.4126)
WAe001-A-O
(H1.0-29/H1.4-14)
WAe001-A-92
(H1.4-143, H1.4143)
WAe001-A-P
(H1.0-102/H1.4-19)
WAe001-A-93
(H1.5-23, H1.523)
WAe001-A-78
(H1X10, H1X-10)
WAe001-A-94
(H1.528, H1.5-28)
WAe001-A-Q
(H1.0-29/H1.5-6)
WAe001-A-73
(H1-GATAD2B-KO-79#)
WAe001-A-R
(H1.0-102/H1.5-44)
WAe001-A-10
(H1_RB1ex3_G3)
WAe001-A-74
(H1-GATAD2B-KO-81#)
WAe001-A-S
(H1.1-17/H1.2-11)
WAe001-A-11
(H1_RB1ex3_G4)
WAe001-A-T
(H1.1-39/H1.2-9)
WAe001-A-U
(H1.1-17/H1.4-18)
Last update 22nd February 2024
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Hainan Medical University (HNMU)
Owner Hainan Medical University (HNMU)
Distributors
Derivation country China

External Databases

BioSamples SAMEA115343060
Cellosaurus CVCL_D6SS

General Information

Publications
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: allowed
Subclone of

Donor Information

General Donor Information

Sex male
Ethnicity N/A

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.
Family history NO
Is the medical history available upon request? NO
Is clinical information available? NO

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

Donor Relations

Other cell lines of this donor
All cell lines of this donor's relatives

External Databases (Donor)

BioSamples SAMEA7767418

Ethics

Also have a look at the ethics information for the parental line WAe001-A .
Is there an MTA available for the cell line? No
Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? No

hESC Derivation

The source cell information can be found in the parental cell line WAe001-A.

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzyme-free cell dissociation
EDTA
O2 Concentration 21 %
CO2 Concentration 5 %
Medium mTeSR™ 1
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
No

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
SOX2
Yes
POU5F1 (OCT-4)
Yes
SSEA-4
Yes
TRA 1-60
Yes
Score:
Marker Present Absent
mCpG
OCT4
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro directed differentiation
Marker Expressed
sox17
Yes
Morphology
Mesoderm
Ont Id: UBERON_0000926
In vitro directed differentiation
Marker Expressed
TBXT
Yes
Morphology
Ectoderm
Ont Id: UBERON_0000924
In vitro directed differentiation
Marker Expressed
pax6
Yes
Morphology

Microbiology / Virus Screening

Mycoplasma Negative

Certificate of Analysis

Is there a certificate of analysis available?
Yes
Passage:

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
G-Banding
Karyotyping method: G-Banding

Other Genotyping (Cell Line)

Genetic Modification

Disease/phenotype related modifications
Y chromosome azoospermia factor a (AZFa) region has been deleted with CRISPR/Cas9 gene editing tool.
Genetic modifications
AZFa (target)
Gene knock-out
Two sgRNAs and Cas9 protein were assembled and delivered with electroporation into H1 cells. The successfully edited clone was identified with genotyping PCR.
CRISPR-associated (CRISPR/Cas) System
Genetic modifications not related to a disease